Global Drug Eluting Balloon Market to Surpass US$1,163.0

Seattle, Sept. 12, 2022 (GLOBE NEWSWIRE) — According to Coherent Market Insights, the drug-eluting balloon market is estimated at US DOLLARS$ 616.6 million in 2022 and should present a CAGR of 8.3% during the forecast period (2022-2030).

Key trends and analysis of Global Drug Eluting Balloons Market:

The major players operating in the market are focusing on getting new product approvals and launching new products in the market. For example, as of February 2021, according to the United States Food and Drug Administration (FDA), continues to recognize a possible mortality risk with paclitaxel-coated balloons and stents intended to treat new or recurrent atherosclerotic lesions in the femoropopliteal artery. A study of paclitaxel-coated stents and balloons used to treat peripheral arterial disease of the legs found no evidence of harm associated with the devices, appearing to contradict an earlier mortality signal from a meta-analysis the FDA recommended physicians to consider in treatment decisions. The US Food and Drug Administration (FDA) is still monitoring the safety signal with paclitaxel stents in PAD. The researchers noted several limitations to the new study, including a shorter follow-up time of 2.72 years than the meta-analysis, in which the mortality signal was most apparent in years four and five. The results were presented in February 2021, at the virtual meeting of the American College of Cardiology and published in JAMA Internal Medicine. SAFE-PAD researchers said the study is ongoing and will continue to evaluate the safety of the devices until the median follow-up of all patients exceeds five years.

Request a sample copy of this report @ https://www.coherentmarketinsights.com/insight/request-sample/2459

Main market takeaways:

The Global Drug Eluting Balloons Market is Expected to Show a CAGR of 8.3% Over the forecast period, owing to the increase in the geriatric population prone to cardiovascular diseases, is expected to drive the demand for angioplasty which in turn is expected to drive the growth of the market. For example, in May 2021, according to the Center for Disease Control and Prevention, 14.2% of adults age 45 and older reported having coronary heart disease (CHD), stroke, or both. 9.6% of adults aged 45 to 64 reported having been diagnosed with coronary heart disease or stroke, or both, compared to 21.7% of adults aged 65 and over. According to the Center for Disease Control and Prevention, in India, in 2017-2018, in the population over 60 years of age, the prevalence of self-reported cardiovascular disease was 45% in the wealthiest monthly per capita expenditure quintile (MPCE) and 27% in the poorest MPCE quintile.

Among end-users, the hospital and outpatient service center segment held a dominant position in the drug-eluting balloon market in 2022, due to the high adoption rate of the devices in hospitals and ambulatory service centers.

Competitive Landscape:

The major players operating in the global drug eluting flasks market are Medtronic, Becton, Dickinson and Company (BD), Boston Scientific Corporation, Cook Medical, B. Braun Melsungen AG, Koninklijke Philips NV, Opto Circuits (India) Limited, Terumo Corporation, Surmodics, Inc. and Biotronik

Buy now this research report @ https://www.coherentmarketinsights.com/insight/buy-now/2459

Market segmentation :

  • Global Drug Eluting Balloon Market, By Product Type:
    • Drug Eluting Coronary Balloon
    • Drug Eluting Peripheral Balloon
    • Others
  • Global M Drug Eluting Balloonmarket, by end user:
    • Hospitals
    • CATH Laboratories
    • Ambulatory surgery centers
    • Others
  • Global Drug Eluting Balloon Market, By Region:
    • North America
    • Latin America
      • By country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By country
        • Germany
        • UK
        • France
        • Italy
        • Spain
        • Russia
        • The rest of Europe
    • Asia Pacific
      • By country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia-Pacific
    • Middle East
      • By country
        • GCC
        • Israel
        • Rest of the Middle East
    • Africa
      • By region/country
        • South Africa
        • central Africa
        • North Africa

Related Market Information Reports:

Eye implant marketby type of implant (intraocular lenses (IOLs) (aspherical IOLs, toric IOLs, multifocal IOLs, anterior chamber IOLs and others), corneal implants, glaucoma implants, orbital implants, ocular prosthesis and others), by application (surgery of the Glaucoma, Oculoplasty, Drug Administration, Age-Related Macular Degeneration (AMD), Aesthetic Purpose and Others) and by Region (North America, Latin America, Europe, Asia-Pacific, Middle East and Africa) – Size, Share, Outlook and Opportunity Analysis, 2022 – 2030

Electroporation Instruments Marketby product type (systems and accessories (electrodes, cuvettes, chambers, kits, others)), by application (protein production, drug delivery, biomedical research, gene therapy, ablation (oncology, cardiology, others), others), by mode (In-Vitro/Clinical and In-Vivo), by End User (Biopharmaceutical, Enterprises, Hospitals, Research and University, Institutes, Others) and by Region (North America, Latin America, Europe, Asia-Pacific, Middle (East & Africa) Size, Share, Prospects & Opportunities Analysis, 2022 – 2030

About Us:

Consistent market information is a global market intelligence and advisory organization focused on helping our plethora of clients achieve transformational growth by helping them make critical business decisions. Our head office is in India, with a sales office in the world’s financial capital in the USA and sales advisors in the UK and Japan. Our customer base includes players from various industries in more than 57 countries around the world. We create value for our clients through our highly reliable and accurate reports. We are also committed to playing a leadership role in providing insights in various post-COVID-19 sectors and to continuing to deliver measurable and sustainable results to our clients.

Follow us: LinkedIn | Twitter